Dan Peisert is the Chief Executive Officer of Assertio, a commercial pharmaceutical company that focuses on offering differentiated products to patients.
Dan Peisert is the Chief Executive Officer of Assertio, a commercial pharmaceutical company that focuses on offering differentiated products to patients through a non-personal promotional model. Assertio's product portfolio includes Indocin, for the treatment of moderate to severe rheumatoid arthritis, and they acquired Spectrum Pharmaceuticals, Inc. in July 2023, which added the injection asset Rolvedon to their offerings.
Full founder directory · Investor directory · Company funding database · Fundraising library